Medical Device News Magazine

Dr Cory Calendine Appointed to Osso VR Advisory Board

Orthopedic surgeon at Bone and Joint Institute of Tennessee joins Osso VR to advance global development and adoption of VR surgical training technology

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Dr Cory Calendine, M.D., an orthopedic surgeon at the Bone and Joint Institute of Tennessee, has officially joined the Osso VR Clinical Advisory Board.

Dr Cory Calendine’s extensive experience in arthroplasty and advanced surgical technologies provides Osso VR and its executive team a valuable resource to accelerate the development of the company’s leading surgical training platform.

Dr. Calendine is a board-certified orthopaedic surgeon specializing in both traditional and robotic total joint arthroplasty. He received his medical degree from the University of Tennessee College of Medicine, completed a residency in orthopaedic surgery at Vanderbilt University Medical Center, and did his fellowship training in adult reconstruction of the hip and knee at the world-renowned Anderson Orthopaedic Research Institute in Alexandria, Virginia.
“I am humbled and honored to be joining the Osso VR advisory board. Osso VR is on the cutting edge of surgical training technology and is producing world-changing technology at a truly global scale. In addition, the team has such a warm, fun-loving culture.  At the end of the day, I was drawn not just to their technology and culture, but also to their mission of democratizing global access to the latest surgical techniques, something that I am extremely passionate about and proud to be a part of.” said Dr. Cory Calendine, M.D.
Osso VR’s surgical training technology provides on-demand, immersive experiences that are effective, repeatable, and measurable to help surgeons reach proficiency with new procedures and devices. The platform has become integral to surgical training programs worldwide and is currently used by thousands of surgeons each month in 20+ leading teaching hospitals and over 15 top medical device companies in over 20 countries.
“I’ve admired the work of Dr. Calendine for years, and I am humbled that he’s joined our advisory board team to continue driving our technology and VR surgical adoption throughout the globe. Innovation in healthcare is not just about developing new technology but also how you communicate about that technology. Dr. Calendine is reshaping the way we are thinking about communication partially through his innovative use of social media to educate healthcare professionals and the public on the value of emerging medical technologies.” said Justin Barad, MD, CEO and co-founder of Osso VR. “Dr. Calendine not only brings his unique expertise to Osso VR, but he also has a passion for democratizing healthcare which is a core part of our mission.”
Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”